Christopher Binny
About Christopher Binny
Christopher Binny is a Senior Virologist at Asklepios BioPharmaceutical, Inc. (AskBio Europe) with extensive experience in AAV vector design and gene therapy development.
Work at Asklepios BioPharmaceutical
Christopher Binny serves as a Senior Virologist at Asklepios BioPharmaceutical, Inc. (AskBio) since 2019. In this role, he focuses on vector bioprocessing and transgene expression regulation, which are essential for the development of effective gene therapies. His work contributes to the advancement of AAV vector design and production, enhancing the understanding of gene therapy applications.
Current Role at Synpromics Ltd
Christopher Binny has been working at Synpromics Ltd as a Senior Virologist since 2018. His responsibilities include conducting research related to virology, specifically in the areas of vector bioprocessing and transgene expression regulation. His expertise supports the development of innovative solutions in gene therapy.
Education and Expertise
Christopher Binny earned a Bachelor of Science (BSc) in Virology from the University of Warwick, studying from 2002 to 2005. He later obtained a Doctor of Philosophy (PhD) in Oncolytic Virotherapy from Queen Mary, University of London, from 2005 to 2009. His educational background provides a strong foundation for his expertise in AAV vector design and production.
Previous Experience at University of Sheffield
Christopher Binny worked as a Postdoctoral Research Associate at the University of Sheffield from 2012 to 2014 and again from 2015 to 2016. During his time there, he contributed to various research projects, enhancing his knowledge and skills in virology and related fields.
Research Focus and Contributions
Christopher Binny's research primarily focuses on pre-clinical in vivo work, which enhances the understanding of AAV biology for cell line development. His contributions are significant in the context of gene therapy, particularly in vector bioprocessing and transgene expression regulation.